Document


Yield10 Bioscience, Inc.
19 Presidential Way
Woburn, Massachusetts 01801

October 28, 2019

VIA EDGAR

U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549

Attention: Edward M. Kelly, Esq.
 
 
 
 
 
 
 
Re:
 
Yield10 Bioscience, Inc.
 
 
 
 
Registration Statement on Form S-1
 
 
 
 
File No. 333-221283
 
 
 
 
Request for Acceleration
Dear Mr. Kelly:
Pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, Yield10 Bioscience, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-233683), so that it may become effective at 5:00 p.m. (Washington, D.C. time) on October 30, 2019, or as soon thereafter as practicable.
Please call Megan Gates, of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (617) 348-4443 with any comments or questions regarding this matter.
 
Very truly yours,


Yield10 Bioscience, Inc.
 
 
By:
/s/ Charles B. Haaser
 
 
 
Name:
Charles B. Haaser
 
 
 
Title:
Vice President, Finance, Chief Accounting Officer and Treasurer
 

cc:    Yield10 Bioscience, Inc.
Oliver P. Peoples, Ph.D.

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Megan N. Gates, Esq.